Henry-Riyad and Tidwell
701
pentane carboxylic acid (7b). IR (CDCl3) (cm–1): 3513,
1701. H NMR (500 MHz, CDCl3) δ: 1.06–2.38 (m, 24),
mer), 1.48–1.53 (m, 1, Z-isomer), 1.73 (distorted q, 2,
CH2CH2CH2), 2.00–2.35 (m, 4), 4.80 (dd, 1, J = 10.6,
6.3 Hz, c-PrHCH=CH, Z-isomer), 4.98 (dd, 1, J = 12.3,
8.2 Hz, c-PrHCH=CH, E-isomer), 5.23 (s, 1, COCHN2),
5.28 (dt, 1, J = 10.4, 9.9 Hz, CH=CHCH2, Z-isomer), 5.45
(dt, 1, J = 13.2, 6.4 Hz, CH=CHCH2, E-isomer). 13C NMR
(100 MHz, CDCl3) δ: 7.2, 10.0, 13.9, 25.4, 27.2, 32.2, 126.9
(CH=CHCH2), 135.3 (c-PrCH=CH), 195.2 (CO). EI-MS
m/z: 179 (MH+), 149 (M+ – N2), 135, 121, 107, 91. HR-EI-
MS m/z calcd. for C10H14N2O: 179.1186; found: 179.1184.
1
2.78–2.80 (m, 1, CHCHOTPh), 2.98–3.02 (m, 1, CHCO2H),
4.80 (d, 1, CHOTPh) J = 8.9 Hz), 7.23–7.36 (m, 5, Ar). 13C
NMR (125 MHz, CDCl3) δ: 17.4, 21.5, 22.9, 25.4, 30.3,
31.8, 38.5, 40.0, 46.9, 47.7, 53.7, 61.2, 88.8 (CHOTPh),
126.5, 127.6, 128.0, 128.6, 129.1, 130.1, 130.4, 139.7, 178.9
(CO). EI-MS (m/z): 360 (M+), 293, 239, 203, 185, 157, 142,
125, 91, 69, 55. HR-EI-MS (m/z) calcd. for C22H34NO3:
360.2534; found: 360.2539.
6-Cyclopropyl-5-hexenoic acid (10)
5-Cyclopropyl-4-pentenylketene (1c) and reaction with
TEMPO
4-Carboxy-n-butyltriphenylphosphonium bromide (5 g,
11.3 mmol) in THF (15 mL) was treated with lithium
hexamethyldisilazide (23.7 mmol) in THF (4 mL) at 25°C
with stirring. After 15 min, cyclopropanecarboxaldehyde
(0.79 g, 11.3 mmol) in THF (5 mL) was added at 25°C, rap-
idly decolorizing the red-orange mixture. After 15 min, wa-
ter (25 mL) and ether (25 mL) were added. The organic
phase was rinsed with 20 mL of water. The combined aque-
ous solution was washed with EtOAc (25 mL), acidified
with 10% HCl, and extracted with EtOAc. The united
EtOAc extracts were rinsed with H2O, dried with Na2SO4,
and concentrated. Kugelrohr distillation gave 10 (1.12 g,
1-Diazo-7-cyclopropyl-6-hepten-2-one (2c, 100 mg,
0.56 mmol) in pentane (75 mL) was photolyzed for 30 min
with 250-nm light to give ketene 1c (IR: 2119 cm–1).
TEMPO (183 mg, 1.18 mmol, 2.1 equiv) was added to the
preformed ketene and the solution was left stirring at room
temperature for 24 h. Chromatography with CH2Cl2 gave 4c
(191 mg, 0.40 mmol, 71%) E/Z isomers (50:50). IR (CDCl3)
1
(cm–1): 1770. H NMR (400 MHz, CDCl3) δ: 0.28–0.31 (m,
2), 0.62–0.65 (m, 2, E-isomer), 0.68–0.72 (m, 2, Z-isomer),
1.08–2.20 (m, 43), 4.48 (distorted t, 1, CH2CHOT), 4.75 (dd,
1, J = 10.2, 7.3 Hz, c-PrHCH=CH, Z-isomer), 4.92 (dd, 1,
J = 9.4, 8.2 Hz, CH=CHCH2, E-isomer), 5.31 (dt, 1, c-
PrHCH=CH, Z-isomer), 5.45 (dt, 1, J = 13.9, 7.5 Hz,
CH=CHCH2, E-isomer). 13C NMR (100 MHz, CDCl3) δ:
6.6, 7.1, 9.8, 13.7, 17.2, 17.4, 20.8, 20.9, 24.7, 24.9, 27.8,
32.1, 32.3, 32.4, 32.6, 34.8, 39.5, 40.7, 60.2, 60.5, 83.7
(CHOT), 127.6, 127.7 (CH=CHCH2), 134.6, 134.7 (c-
PrCH=CH), 171.9 (CO2T). EI-MS m/z: 464 (MH+), 448
(M+ – CH3), 322 (M+ – T), 306, 278, 182, 156 (TO+), 140
(T+), 126, 83, 55. HR-EI-MS m/z calcd. for MH+
C28H51N2O3: 463.3869; found: 463.3899.
1
64%) (E/Z isomers, 1:1). H NMR (400 MHz, CDCl3) δ:
0.30–0.32 (m, 2), 0.63–0.67 (m, 2, E-isomer), 0.69–0.73 (m,
2, Z-isomer), 1.49–1.58 (m, 1), 1.65–2.41 (m, 6), 4.80 (dd,
1, J = 10.6, 9.8 Hz, c-PrHCH=CH, Z-isomer), 5.02 (dd, 1,
J = 15.2, 8.2 Hz, c-PrHCH=CH, E-isomer), 5.30 (dt, 1, J =
10.6, 6.2 Hz, CH=CHCH2, Z-isomer), 5.45 (dt, 1, J = 15.2,
6.4 Hz, CH=CHCH2, E-isomer).
6-Cyclopropyl-5-hexenoyl chloride
Oxalyl chloride (1.05 g, 8 mmol) was added dropwise to a
stirred solution of 6-cyclopropyl-5-hexenoic acid (10, 0.76 g,
4 mmol) in CCl4 (10 mL) and stirred for 2 h. The solvent
was removed in vaccuo to give 6-cyclopropyl-5-hexenoyl
chloride as a dark brown oil (1.20 g, 92%) containing E/Z
Thermolysis of 4c
The bis-TEMPO adduct 4c (50 mg, 0.108 mmol) in de-
gassed t-BuOH (5 mL) was heated in a sealed ampoule at
130°C for 18 h. GC analysis indicated the presence of
2,2,6,6-tetramethylpiperidine (15 ± 2%). Concentration and
chromatography (CHCl3–MeOH, 9:1) afforded the cyclized
ester 11 containing carboxylic acid. IR (CDCl3) (cm–1):
3512, 1740, 1702. Base extraction and chromatography
(CH2Cl2–MeOH, 9:1) afforded ester 11 (32 mg,
0.069 mmol, 65%). IR (CDCl3) (cm–1): 1750. 1H NMR
(500 MHz, CDCl3) δ: 1.08–2.00 (m, 42), 2.22 (dt, 2,
CH2CH2OT), 2.51 (m, 1, Z-CHCO2T), 2.79 (m, 1, E-
CHCO2T), 3.71–3.74 (t, 2, J= 6.71 Hz, CH2OT), 5.43–5.48
(m, 1, c-PnCH=CH), 5.52–5.56 (m, 1, c-PnCH=CH). 13C
NMR (125 MHz, CDCl3) δ: 17.4, 20.4, 20.8, 24.2, 24.8,
25.0. 30.0, 30.4, 31.5, 32.2, 33.3, 33.6, 39.8, 47.7, 50.4,
56.0, 76.5 (CH2OT), 127.5 (CH=CHCH2), 133.9 (c-
PnCH=CH), 180.6 (CO2T). EI-MS m/z: 463 (MH+), 447
(M+ – CH3), 306 (M+ – OT), 278 (M+ – CO2T), 182, 156
(TO), 140 (T), 126, 109, 93, 83, 69, 55. HR-EI-MS m/z
calcd. for C28H50N2O3: 462.3816; found: 462.3821.
1
(50:50), used subsequently without further purification. H
NMR (400 MHz, CDCl3) δ: 0.31–0.32 (m, 2), 0.71–0.73 (m,
2, E-isomer), 0.74–0.79 (m, 2, Z-isomer), 1.52–1.6 (m, 1),
1.90 (distorted q, 2, CH2CH2CH2), 2.32 (dt, 2, CHCH2CH2),
3.05 (t, 2, J = 7.2 Hz, CH2COCl), 4.84 (dd, 1, J = 10.5,
8.4 Hz, c-PrHCH, Z-isomer), 5.20 (dd, 1, J = 13.2, 7.7 Hz,
c-PrHCH=CH, E-isomer), 5.35 (dt, 1, J = 9.4, 7.5 Hz,
CH=CHCH2, Z-isomer), 5.50 (dt, 1, J = 11.4, 8.5 Hz,
CH=CHCH2, E-isomer).
1-Diazo-7-cyclopropyl-6-hepten-2-one (2c)
6-Cyclopropyl-5-hexenoyl chloride (1.20 g, 7.0 mmol) in
ether (5 mL) was added dropwise over a period of 0.5 h to a
stirring cooled solution of 0.018 mol of diazomethane (3
equiv) in ether (60 mL) which the solution was stirred at
0°C for 2 h. Excess diazomethane was removed by evacuat-
ing with a water aspirator through an empty Erlenmeyer
flask and quenched in acetic acid, and the solution was con-
centrated. Chromatography (EtOAc–hexane, 3:7) gave 2c
(0.92 g, 5.2 mmol, 74%) as a yellow oil containing E/Z iso-
Allyloxyacetyl chloride
mers (47:53). IR (pentane) (cm–1): 2102, 1662. H NMR
(400 MHz, CDCl3) δ: 0.29–0.32 (m, 2), 0.63–0.66 (m, 2, E-
isomer), 0.69–0.74 (m, 2, Z-isomer), 1.32–1.34 (m, 1, E-iso-
Oxalyl chloride (3.99 g, 2.7 mL, 0.03 mol) was added
dropwise to a stirred solution of allyloxyacetic acid (7 h,
1.75 g, 0.015 mol) in dichloromethane (20 mL) followed by
1
© 2003 NRC Canada